37:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
the renin angiotensin aldosterone system :@0.076190:0.099847:0.754867:0.099847:0.754867:0.063183:0.076190:0.063183:0.014111:0.020159:0.021503:0.009407:0.010751:0.021503:0.020159:0.008063:0.020159:0.009407:0.022175:0.020159:0.022175:0.008063:0.021503:0.010079:0.021503:0.020159:0.014783:0.008063:0.020159:0.009407:0.022175:0.008063:0.022175:0.021503:0.014783:0.010079:0.021503:0.010751:0.021503:0.020159:0.021503:0.009407:0.014783:0.019487:0.014783:0.010079:0.021503:0.031582:0.009407
antagonism (rAAs) and clinical outcomes:@0.076190:0.128069:0.763603:0.128069:0.763603:0.091406:0.076190:0.091406:0.022175:0.020159:0.010079:0.022175:0.022175:0.021503:0.020159:0.008063:0.014783:0.031582:0.009407:0.012767:0.019487:0.024862:0.024862:0.017471:0.012767:0.009407:0.022175:0.020159:0.022175:0.009407:0.021503:0.008063:0.008063:0.020159:0.008063:0.021503:0.022175:0.008063:0.009407:0.021503:0.020159:0.010079:0.021503:0.021503:0.031582:0.021503:0.014783
Jr snyman:@0.076190:0.169924:0.164217:0.169924:0.164217:0.151592:0.076190:0.151592:0.008063:0.009743:0.004704:0.008735:0.010079:0.009743:0.015791:0.011087:0.010079
MBChB (pret), MpharmMed, MD:@0.076190:0.182033:0.283892:0.182033:0.283892:0.168004:0.076190:0.168004:0.012351:0.007714:0.010926:0.008198:0.007714:0.003723:0.004959:0.007956:0.004045:0.008735:0.004556:0.004959:0.003723:0.003723:0.012351:0.007956:0.008198:0.009179:0.004045:0.012606:0.012351:0.008735:0.009206:0.003723:0.003723:0.012351:0.009999
Medical Specialist Holdings (Pty) Ltd, Cape Town:@0.076190:0.200064:0.392615:0.200064:0.392615:0.186035:0.076190:0.186035:0.012351:0.008735:0.009206:0.002688:0.008695:0.009179:0.002688:0.003723:0.006693:0.009165:0.008735:0.008695:0.002688:0.009179:0.002688:0.002688:0.005214:0.004556:0.003723:0.009179:0.008803:0.002688:0.009206:0.002688:0.008198:0.009045:0.005214:0.003723:0.004959:0.007956:0.004556:0.007203:0.004959:0.003723:0.006209:0.004556:0.009206:0.003723:0.003723:0.010926:0.009179:0.009165:0.008735:0.003723:0.005725:0.008803:0.011168:0.008198
Clinical  outcomes  are often  distant from  the  time of :@0.076190:0.230029:0.485130:0.230029:0.485130:0.214246:0.076190:0.214246:0.012292:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188:0.003372:0.009903:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188:0.003341:0.010326:0.004551:0.009827:0.007544:0.009903:0.004747:0.005125:0.009827:0.009223:0.004188:0.003341:0.010357:0.003024:0.005866:0.005125:0.010326:0.009223:0.005125:0.007544:0.004747:0.004551:0.009903:0.014182:0.004188:0.003341:0.005125:0.009223:0.009827:0.004188:0.003341:0.005125:0.003024:0.014182:0.009827:0.007544:0.009903:0.004747:0.004188
treatment initiation and the clinician may fall into the :@0.076190:0.244206:0.485145:0.244206:0.485145:0.228424:0.076190:0.228424:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.006335:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.006350:0.010326:0.009223:0.010357:0.006335:0.005125:0.009223:0.009827:0.006335:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.003024:0.010326:0.009223:0.006350:0.014182:0.010326:0.008104:0.006350:0.004747:0.010326:0.003024:0.003024:0.006350:0.003024:0.009223:0.005125:0.009903:0.006335:0.005125:0.009223:0.009827:0.004188
trap of trying something new as the true clinical benefit :@0.076190:0.258384:0.485145:0.258384:0.485145:0.242602:0.076190:0.242602:0.005125:0.004551:0.010326:0.010311:0.004385:0.009903:0.004747:0.004385:0.005125:0.004551:0.008104:0.003024:0.009223:0.010175:0.004385:0.005866:0.009903:0.014182:0.009827:0.005125:0.009223:0.003024:0.009223:0.010175:0.004385:0.009223:0.009827:0.012564:0.004385:0.010326:0.005866:0.004400:0.005125:0.009223:0.009827:0.004385:0.005125:0.004551:0.009192:0.009827:0.004385:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004400:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.004188
of treatment is not always proximal to the intervention :@0.076190:0.272562:0.485160:0.272562:0.485160:0.256779:0.076190:0.256779:0.009903:0.004747:0.005655:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005639:0.003024:0.005866:0.005655:0.009223:0.009903:0.005125:0.005655:0.010326:0.003024:0.012564:0.010326:0.008104:0.005866:0.005670:0.010311:0.004551:0.009903:0.007257:0.003024:0.014182:0.010326:0.003024:0.005655:0.005125:0.009903:0.005655:0.005125:0.009223:0.009827:0.005655:0.003024:0.009223:0.005125:0.009827:0.004551:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.004188
prescribed. Lowering blood pressure is easy and can be :@0.076190:0.286740:0.485130:0.286740:0.485130:0.270957:0.076190:0.270957:0.010311:0.004551:0.009827:0.005866:0.009782:0.004551:0.003024:0.010311:0.009827:0.010357:0.004188:0.003750:0.006985:0.009903:0.012564:0.009827:0.004551:0.003024:0.009223:0.010175:0.003750:0.010311:0.003024:0.009903:0.009903:0.010357:0.003750:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.003750:0.003024:0.005866:0.003765:0.009827:0.010326:0.005866:0.008104:0.003765:0.010326:0.009223:0.010357:0.003750:0.009782:0.010326:0.009223:0.003750:0.010311:0.009827:0.004188
done with a myriad of medicines. The challenge for the :@0.076190:0.300918:0.485145:0.300918:0.485145:0.285135:0.076190:0.285135:0.010357:0.009903:0.009223:0.009827:0.004158:0.012564:0.003024:0.005125:0.009223:0.004158:0.010326:0.004158:0.014182:0.008104:0.004551:0.003024:0.010326:0.010357:0.004158:0.009903:0.004747:0.004158:0.014182:0.009827:0.010357:0.003024:0.009782:0.003024:0.009223:0.009827:0.005866:0.004188:0.004158:0.006441:0.009223:0.009827:0.004158:0.009782:0.009223:0.010326:0.003024:0.003024:0.009827:0.009223:0.010175:0.009827:0.004158:0.004747:0.009903:0.004551:0.004143:0.005125:0.009223:0.009827:0.004188
clinician is which one will best protect the patient’s end :@0.076190:0.315096:0.485145:0.315096:0.485145:0.299313:0.076190:0.299313:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.003024:0.010326:0.009223:0.004188:0.003024:0.005866:0.004173:0.012564:0.009223:0.003024:0.009782:0.009223:0.004173:0.009903:0.009223:0.009827:0.004173:0.012564:0.003024:0.003024:0.003024:0.004188:0.010311:0.009827:0.005866:0.005125:0.004173:0.010311:0.004551:0.009903:0.005125:0.009827:0.009782:0.005125:0.004158:0.005125:0.009223:0.009827:0.004173:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005307:0.005866:0.004173:0.009827:0.009223:0.010357:0.004188
organs over time, resulting in a reduction  in mortality. :@0.076190:0.329273:0.485145:0.329273:0.485145:0.313491:0.076190:0.313491:0.009903:0.004551:0.010175:0.010326:0.009223:0.005866:0.006547:0.009903:0.008376:0.009827:0.004551:0.006547:0.005125:0.003024:0.014182:0.009827:0.004188:0.006547:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.003024:0.009223:0.010175:0.006547:0.003024:0.009223:0.006547:0.010326:0.006547:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.002343:0.003024:0.009223:0.006547:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.004188
This is even more relevant when the patient suffers mul-:@0.076190:0.343451:0.480927:0.343451:0.480927:0.327669:0.076190:0.327669:0.006441:0.009223:0.003024:0.005866:0.004566:0.003024:0.005866:0.004581:0.009827:0.008376:0.009827:0.009223:0.004566:0.014182:0.009903:0.004551:0.009827:0.004566:0.004551:0.009827:0.003024:0.009827:0.008376:0.010326:0.009223:0.005125:0.004566:0.012564:0.009223:0.009827:0.009223:0.004566:0.005125:0.009223:0.009827:0.004566:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004566:0.005866:0.009192:0.004747:0.004747:0.009827:0.004551:0.005866:0.004566:0.014182:0.009192:0.003024:0.005020
tiple comorbidities, such as diabetes mellitus, renal dis-:@0.076190:0.357629:0.480957:0.357629:0.480957:0.341846:0.076190:0.341846:0.005125:0.003024:0.010311:0.003024:0.009827:0.005261:0.009782:0.009903:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.003024:0.009827:0.005866:0.004188:0.005261:0.005866:0.009192:0.009782:0.009223:0.005246:0.010326:0.005866:0.005261:0.010357:0.003024:0.010326:0.010311:0.009827:0.005125:0.009827:0.005866:0.005261:0.014182:0.009827:0.003024:0.003024:0.003024:0.005125:0.009192:0.005866:0.004188:0.005261:0.004551:0.009827:0.009223:0.010326:0.003024:0.005246:0.010357:0.003024:0.005866:0.005020
ease and cognitive impairment. The renin angiotensin :@0.076190:0.371807:0.485145:0.371807:0.485145:0.356024:0.076190:0.356024:0.009827:0.010326:0.005866:0.009827:0.006063:0.010326:0.009223:0.010357:0.006048:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.008376:0.009827:0.006063:0.003024:0.014182:0.010311:0.010326:0.003024:0.004551:0.014182:0.009827:0.009223:0.005125:0.004188:0.006048:0.006441:0.009223:0.009827:0.006048:0.004551:0.009827:0.009223:0.003024:0.009223:0.006048:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.004188
aldosterone system (RAAS) has been identified as the :@0.076190:0.385985:0.485145:0.385985:0.485145:0.370202:0.076190:0.370202:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.006350:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.006365:0.005579:0.009177:0.011188:0.011188:0.007529:0.005579:0.006350:0.009223:0.010326:0.005866:0.006365:0.010311:0.009827:0.009827:0.009223:0.006365:0.003024:0.010357:0.009827:0.009223:0.005125:0.003024:0.003681:0.003681:0.009827:0.010357:0.006365:0.010326:0.005866:0.006365:0.005125:0.009223:0.009827:0.004188
major contributor to the pathology of many of the vas-:@0.076190:0.400162:0.480912:0.400162:0.480912:0.384380:0.076190:0.384380:0.014182:0.010326:0.003069:0.009903:0.004551:0.004657:0.009782:0.009903:0.009223:0.005125:0.004551:0.003024:0.010311:0.009192:0.005125:0.009903:0.004551:0.004642:0.005125:0.009903:0.004642:0.005125:0.009223:0.009827:0.004642:0.010311:0.010326:0.005125:0.009223:0.009903:0.003024:0.009903:0.010175:0.008104:0.004642:0.009903:0.004747:0.004642:0.014182:0.010326:0.009223:0.008104:0.004657:0.009903:0.004747:0.004642:0.005125:0.009223:0.009827:0.004642:0.008376:0.010326:0.005866:0.005020
cular and even non-vascular-related conditions (meta-:@0.076190:0.414340:0.480957:0.414340:0.480957:0.398558:0.076190:0.398558:0.009782:0.009192:0.003024:0.010326:0.004551:0.004475:0.010326:0.009223:0.010357:0.004475:0.009827:0.008376:0.009827:0.009223:0.004475:0.009223:0.009903:0.009223:0.005020:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.005020:0.004551:0.009827:0.003024:0.010326:0.005125:0.009827:0.010357:0.004475:0.009782:0.009903:0.009223:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.005866:0.004475:0.005579:0.014182:0.009827:0.005125:0.010326:0.005020
bolic disorders), often closely associated with elevated :@0.076190:0.428518:0.485130:0.428518:0.485130:0.412735:0.076190:0.412735:0.010311:0.009903:0.003024:0.003024:0.009782:0.004883:0.010357:0.003024:0.005866:0.009903:0.004551:0.010357:0.009827:0.004551:0.005866:0.005579:0.004188:0.004868:0.009903:0.004747:0.005125:0.009827:0.009223:0.004868:0.009782:0.003024:0.009903:0.005866:0.009827:0.003024:0.008104:0.004883:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004883:0.012564:0.003024:0.005125:0.009223:0.004868:0.009827:0.003024:0.009827:0.008376:0.010326:0.005125:0.009827:0.010357:0.004188
blood  pressure.  Blocking the  effect  of  the  RAAs  has :@0.076190:0.442696:0.485130:0.442696:0.485130:0.426913:0.076190:0.426913:0.010311:0.003024:0.009903:0.009903:0.010357:0.004188:0.003825:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188:0.004188:0.003825:0.008678:0.003024:0.009903:0.009782:0.007590:0.003024:0.009223:0.010175:0.008028:0.005125:0.009223:0.009827:0.004188:0.003825:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004188:0.003825:0.009903:0.004747:0.004188:0.003825:0.005125:0.009223:0.009827:0.004188:0.003825:0.009177:0.011188:0.011188:0.007529:0.004188:0.003825:0.009223:0.010326:0.005866:0.004188
been the focus of extensive research, first with the an:@0.076190:0.456874:0.475938:0.456874:0.475938:0.441091:0.076190:0.441091:0.010311:0.009827:0.009827:0.009223:0.005458:0.005125:0.009223:0.009827:0.005473:0.004747:0.009903:0.009782:0.009192:0.005866:0.005473:0.009903:0.004747:0.005458:0.009827:0.007257:0.005125:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.005473:0.004551:0.009827:0.005866:0.009827:0.010326:0.004551:0.009782:0.009223:0.004188:0.005458:0.003681:0.003681:0.004551:0.005866:0.005125:0.005458:0.012564:0.003024:0.005125:0.009223:0.005473:0.005125:0.009223:0.009827:0.005458:0.010326:0.009223
-:@0.475938:0.456874:0.480957:0.456874:0.480957:0.441091:0.475938:0.441091:0.005020
giotensin-converting enzyme inhibitors (ACEIs), followed :@0.076190:0.471051:0.485145:0.471051:0.485145:0.455269:0.076190:0.455269:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.005020:0.009782:0.009903:0.009223:0.008376:0.009827:0.004551:0.005125:0.003024:0.009223:0.010175:0.003674:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.003674:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.003689:0.005579:0.011188:0.012292:0.008104:0.003417:0.005866:0.005579:0.004188:0.003689:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.009827:0.010357:0.004188
by the angiotensin-1-receptor blockers (ARBs), then by :@0.076190:0.485229:0.485130:0.485229:0.485130:0.469447:0.076190:0.469447:0.010311:0.008104:0.005337:0.005125:0.009223:0.009827:0.005337:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009812:0.009223:0.005866:0.003024:0.009223:0.005020:0.008376:0.005020:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.005337:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.005337:0.005579:0.011188:0.009177:0.008678:0.005866:0.005579:0.004188:0.005337:0.005125:0.009223:0.009827:0.009223:0.005337:0.010311:0.008104:0.004188
combinations of the two. The latter was in turn followed :@0.076190:0.499407:0.485145:0.499407:0.485145:0.483624:0.076190:0.483624:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004264:0.009903:0.004747:0.004264:0.005125:0.009223:0.009827:0.004264:0.005125:0.012564:0.009903:0.004188:0.004264:0.006441:0.009223:0.009827:0.004264:0.003024:0.010326:0.005125:0.005125:0.009827:0.004551:0.004264:0.012564:0.010326:0.005866:0.004264:0.003024:0.009223:0.004264:0.005125:0.009192:0.004551:0.009223:0.004248:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.009827:0.010357:0.004188
by renin antagonists and combinations with the ARBs or :@0.076190:0.513585:0.485130:0.513585:0.485130:0.497802:0.076190:0.497802:0.010311:0.008104:0.004143:0.004551:0.009827:0.009223:0.003024:0.009223:0.004127:0.010326:0.009223:0.005125:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.005866:0.004127:0.010326:0.009223:0.010357:0.004127:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004127:0.012564:0.003024:0.005125:0.009223:0.004127:0.005125:0.009223:0.009827:0.004127:0.011188:0.009177:0.008678:0.005866:0.004127:0.009903:0.004551:0.004188
ACEIs. Direct aldosterone antagonists were also added :@0.076190:0.527763:0.485145:0.527763:0.485145:0.511980:0.076190:0.511980:0.011188:0.012292:0.008104:0.003417:0.005866:0.004188:0.004490:0.011249:0.003024:0.004551:0.009827:0.009782:0.005125:0.004490:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.004475:0.010326:0.009223:0.005125:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.005866:0.004490:0.012564:0.009827:0.004551:0.009827:0.004490:0.010326:0.003024:0.005866:0.009903:0.004490:0.010326:0.010357:0.010357:0.009827:0.010357:0.004188
to the mix, with good results in selected patients. The :@0.076190:0.541941:0.485130:0.541941:0.485130:0.526158:0.076190:0.526158:0.005125:0.009903:0.006531:0.005125:0.009223:0.009827:0.006531:0.014182:0.003024:0.007257:0.004188:0.006531:0.012564:0.003024:0.005125:0.009223:0.006531:0.010175:0.009903:0.009903:0.010357:0.006531:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.006531:0.003024:0.009223:0.006531:0.005866:0.009827:0.003024:0.009827:0.009782:0.005125:0.009827:0.010357:0.006531:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004188:0.006531:0.006441:0.009223:0.009827:0.004188
research  studies  firstly  aimed  to  address  hypertension, :@0.076190:0.556118:0.485160:0.556118:0.485160:0.540336:0.076190:0.540336:0.004551:0.009827:0.005866:0.009827:0.010326:0.004551:0.009782:0.009223:0.004188:0.002343:0.005866:0.005125:0.009192:0.010357:0.003024:0.009827:0.005866:0.004188:0.002359:0.003681:0.003681:0.004551:0.005866:0.005125:0.003024:0.008104:0.004188:0.002359:0.010326:0.003024:0.014182:0.009827:0.010357:0.004188:0.002359:0.005125:0.009903:0.004188:0.002343:0.010326:0.010357:0.010357:0.004551:0.009827:0.005866:0.005866:0.004188:0.002359:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.004188
after which their focus shifted to end-organ protection :@0.076190:0.570296:0.485160:0.570296:0.485160:0.554514:0.076190:0.554514:0.010326:0.004747:0.005125:0.009827:0.004551:0.005216:0.012564:0.009223:0.003024:0.009782:0.009223:0.005231:0.005125:0.009223:0.009827:0.003024:0.004551:0.005231:0.004747:0.009903:0.009782:0.009192:0.005866:0.005231:0.005866:0.009223:0.003024:0.004747:0.005125:0.009827:0.010357:0.005231:0.005125:0.009903:0.005216:0.009827:0.009223:0.010357:0.005020:0.009903:0.004551:0.010175:0.010326:0.009223:0.005216:0.010311:0.004551:0.009903:0.005125:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
involving, for example, the kidneys (renal failure) and :@0.076190:0.584474:0.485130:0.584474:0.485130:0.568691:0.076190:0.568691:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.003024:0.009223:0.010175:0.004188:0.006743:0.004747:0.009903:0.004551:0.006743:0.009827:0.007257:0.010326:0.014182:0.010311:0.003024:0.009827:0.004188:0.006743:0.005125:0.009223:0.009827:0.006743:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.005866:0.006743:0.005579:0.004551:0.009827:0.009223:0.010326:0.003024:0.006743:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.005579:0.006743:0.010326:0.009223:0.010357:0.004188
cardiovascular system (myocardial infarction, heart fail-:@0.076190:0.598652:0.480957:0.598652:0.480957:0.582869:0.076190:0.582869:0.009782:0.010326:0.004551:0.010357:0.003024:0.009903:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.003795:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.003795:0.005579:0.014182:0.008104:0.009903:0.009782:0.010326:0.004551:0.010357:0.003024:0.010326:0.003024:0.003795:0.003024:0.009223:0.004747:0.010326:0.004551:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003780:0.009223:0.009827:0.010326:0.004551:0.005125:0.003780:0.004747:0.010326:0.003024:0.003024:0.005020
ure, atherosclerosis, stroke), and finally to disease-spe:@0.076190:0.612830:0.475938:0.612830:0.475938:0.597047:0.076190:0.597047:0.009192:0.004551:0.009827:0.004188:0.006063:0.010326:0.005125:0.009223:0.009827:0.004551:0.009903:0.005866:0.009782:0.003024:0.009827:0.004551:0.009903:0.005866:0.003024:0.005866:0.004188:0.006063:0.005866:0.005125:0.004551:0.009903:0.007590:0.009827:0.005579:0.004188:0.006063:0.010326:0.009223:0.010357:0.006063:0.003681:0.003681:0.009223:0.010326:0.003024:0.003024:0.008104:0.006078:0.005125:0.009903:0.006063:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005020:0.005866:0.010311:0.009827
-:@0.475938:0.612830:0.480957:0.612830:0.480957:0.597047:0.475938:0.597047:0.005020
cific or all-cause mortality reduction.:@0.076190:0.627007:0.342270:0.627007:0.342270:0.611225:0.076190:0.611225:0.009782:0.003024:0.003681:0.003681:0.009782:0.004188:0.009903:0.004551:0.004188:0.010326:0.003024:0.003024:0.005020:0.009782:0.010326:0.009192:0.005866:0.009827:0.004188:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
rAAs’s rOle in DiseAse:@0.076190:0.659989:0.285722:0.659989:0.285722:0.639824:0.076190:0.639824:0.010718:0.013674:0.013674:0.009609:0.005156:0.008131:0.005174:0.010718:0.015522:0.008131:0.009609:0.005174:0.005174:0.013674:0.005174:0.012935:0.005174:0.009609:0.009609:0.013674:0.009609:0.009609
Figure 1 displays the many important areas where angi-:@0.076190:0.675947:0.480957:0.675947:0.480957:0.660164:0.076190:0.660164:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.004112:0.008376:0.004127:0.010357:0.003024:0.005866:0.010311:0.003024:0.010326:0.008104:0.005866:0.004143:0.005125:0.009223:0.009827:0.004112:0.014182:0.010326:0.009223:0.008104:0.004127:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.004112:0.010326:0.004551:0.009827:0.010326:0.005866:0.004127:0.012564:0.009223:0.009827:0.004551:0.009827:0.004112:0.010326:0.009223:0.010175:0.003024:0.005020
otensin II plays a role in driving end-organ pathology. Im-:@0.076190:0.690125:0.480942:0.690125:0.480942:0.674342:0.076190:0.674342:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.003099:0.003417:0.003417:0.003115:0.010311:0.003024:0.010326:0.008104:0.005866:0.003130:0.010326:0.003115:0.004551:0.009903:0.003024:0.009827:0.003099:0.003024:0.009223:0.003115:0.010357:0.004551:0.003024:0.008376:0.003024:0.009223:0.010175:0.003115:0.009827:0.009223:0.010357:0.005020:0.009903:0.004551:0.010175:0.010326:0.009223:0.003099:0.010311:0.010326:0.005125:0.009223:0.009903:0.003024:0.009903:0.010175:0.008104:0.004188:0.003099:0.003417:0.014182:0.005020
paired kidney perfusion signals renin production which :@0.076190:0.704303:0.485145:0.704303:0.485145:0.688520:0.076190:0.688520:0.010311:0.010326:0.003024:0.004551:0.009827:0.010357:0.005518:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.005518:0.010311:0.009827:0.004551:0.004747:0.009192:0.005866:0.003024:0.009903:0.009223:0.005503:0.005866:0.003024:0.010175:0.009223:0.010326:0.003024:0.005866:0.005518:0.004551:0.009827:0.009223:0.003024:0.009223:0.005503:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005503:0.012564:0.009223:0.003024:0.009782:0.009223:0.004188
converts angiotensinogen to angiotensin I which is then :@0.076190:0.718480:0.485145:0.718480:0.485145:0.702698:0.076190:0.702698:0.009782:0.009903:0.009223:0.008376:0.009827:0.004551:0.005125:0.005866:0.004082:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.009903:0.010175:0.009827:0.009223:0.004067:0.005125:0.009903:0.004082:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.004082:0.003417:0.004082:0.012564:0.009223:0.003024:0.009782:0.009223:0.004082:0.003024:0.005866:0.004082:0.005125:0.009223:0.009827:0.009223:0.004188
changed to angiotensin II by the so-called angiotensin-:@0.076190:0.732658:0.480942:0.732658:0.480942:0.716876:0.076190:0.716876:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.010357:0.004188:0.005125:0.009903:0.004188:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.004188:0.003417:0.003417:0.004203:0.010311:0.008104:0.004203:0.005125:0.009223:0.009827:0.004188:0.005866:0.009903:0.005020:0.009782:0.010326:0.003024:0.003024:0.009827:0.010357:0.004203:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.005020
converting enzyme (ACE). Angiotensin II triggers an ar-:@0.076190:0.746836:0.480957:0.746836:0.480957:0.731053:0.076190:0.731053:0.009782:0.009903:0.009223:0.008376:0.009827:0.004551:0.005125:0.003024:0.009223:0.010175:0.005095:0.009827:0.009223:0.006426:0.008104:0.014182:0.009827:0.005095:0.005579:0.011188:0.012292:0.008104:0.005579:0.004188:0.005095:0.011188:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.005095:0.003417:0.003417:0.005095:0.005125:0.004551:0.003024:0.010175:0.010175:0.009827:0.004551:0.005866:0.005095:0.010326:0.009223:0.005095:0.010326:0.004551:0.005020
ray of  reactions, ranging  from direct  vasoconstriction :@0.076190:0.761014:0.485130:0.761014:0.485130:0.745231:0.076190:0.745231:0.004551:0.010326:0.008104:0.007272:0.009903:0.004747:0.004188:0.003069:0.004551:0.009827:0.010326:0.009782:0.005125:0.003024:0.009903:0.009207:0.005866:0.004188:0.007272:0.004551:0.010326:0.009223:0.010175:0.003024:0.009223:0.010175:0.004188:0.003069:0.004747:0.004551:0.009903:0.014167:0.007272:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.004188:0.003069:0.008376:0.010326:0.005866:0.009903:0.009782:0.009903:0.009223:0.005866:0.005125:0.004551:0.003024:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
by stimulating angiotensin-1 (AT ) receptors; it acts as a :@0.076190:0.775192:0.485153:0.775205:0.485153:0.759423:0.076190:0.759409:0.010311:0.008104:0.004808:0.005866:0.005125:0.003024:0.014182:0.009192:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.004793:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.005020:0.008376:0.002788:0.005579:0.011188:0.006441:0.004855:0.005579:0.004808:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.005866:0.004188:0.004793:0.003024:0.005125:0.004793:0.010326:0.009782:0.005125:0.005866:0.004808:0.010326:0.005866:0.004808:0.010326:-0.165924
 :@0.280831:0.774871:0.283260:0.774871:0.283260:0.765717:0.280831:0.765717:0.002429
1:@0.306818:0.774871:0.311676:0.774871:0.311676:0.765717:0.306818:0.765717:0.004858
growth signal for fibrosis and cell proliferation (ventricu:@0.076183:0.789383:0.475915:0.789383:0.475915:0.773601:0.076183:0.773601:0.010175:0.004551:0.009903:0.012564:0.005125:0.009223:0.004657:0.005866:0.003024:0.010175:0.009223:0.010326:0.003024:0.004672:0.004747:0.009903:0.004551:0.004672:0.003681:0.003681:0.010311:0.004551:0.009903:0.005866:0.003024:0.005866:0.004672:0.010326:0.009223:0.010357:0.004672:0.009782:0.009827:0.003024:0.003024:0.004672:0.010311:0.004551:0.009903:0.003024:0.003024:0.004747:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004672:0.005579:0.008376:0.009827:0.009223:0.005125:0.004551:0.003024:0.009782:0.009192
-:@0.475915:0.789383:0.480935:0.789383:0.480935:0.773601:0.475915:0.773601:0.005020
lar hypertrophy and fibrosis), renal mesangial cell hyper:@0.076183:0.803561:0.475946:0.803561:0.475946:0.787778:0.076183:0.787778:0.003024:0.010326:0.004551:0.003644:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.004551:0.009903:0.010311:0.009223:0.008089:0.003629:0.010326:0.009223:0.010357:0.003644:0.003681:0.003681:0.010311:0.004551:0.009903:0.005866:0.003024:0.005866:0.005579:0.004188:0.003644:0.004551:0.009827:0.009223:0.010326:0.003024:0.003644:0.014182:0.009827:0.005866:0.010326:0.009223:0.010175:0.003024:0.010326:0.003024:0.003644:0.009782:0.009827:0.003024:0.003024:0.003644:0.009223:0.008104:0.010311:0.009827:0.004551
-:@0.475946:0.803561:0.480965:0.803561:0.480965:0.787778:0.475946:0.787778:0.005020
trophy,  endothelial  inflammation  and  atherosclerosis, :@0.076183:0.817739:0.485138:0.817739:0.485138:0.801956:0.076183:0.801956:0.005125:0.004551:0.009903:0.010311:0.009223:0.008104:0.004188:0.004188:0.004264:0.009827:0.009223:0.010357:0.009903:0.005125:0.009223:0.009827:0.003024:0.003024:0.010326:0.003024:0.004188:0.004279:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004279:0.010326:0.009223:0.010357:0.004188:0.004279:0.010326:0.005125:0.009223:0.009827:0.004551:0.009903:0.005866:0.009782:0.003024:0.009827:0.004551:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188
sympathetic nervous system activation (increased sym-:@0.076183:0.831917:0.480935:0.831917:0.480935:0.816134:0.076183:0.816134:0.005866:0.008104:0.014182:0.010311:0.010326:0.005125:0.009223:0.009827:0.005125:0.003024:0.009782:0.004445:0.009223:0.009827:0.004551:0.008376:0.009903:0.009192:0.005866:0.004430:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.004445:0.010326:0.009782:0.005125:0.003024:0.008376:0.010326:0.005125:0.003024:0.009903:0.009223:0.004430:0.005579:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004430:0.005866:0.008104:0.014182:0.005020
pathetic tone and nor-adrenalin circulation), reduction :@0.076183:0.846094:0.485153:0.846094:0.485153:0.830312:0.076183:0.830312:0.010311:0.010326:0.005125:0.009223:0.009827:0.005125:0.003024:0.009782:0.004354:0.005125:0.009903:0.009223:0.009827:0.004354:0.010326:0.009223:0.010357:0.004354:0.009223:0.009903:0.004551:0.005020:0.010326:0.010357:0.004551:0.009827:0.009223:0.010326:0.003024:0.003024:0.009223:0.004354:0.009782:0.003024:0.004551:0.009782:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005579:0.004188:0.004354:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
in pre-adipocyte differentiation, reduction in insulin sen-:@0.076183:0.860272:0.480935:0.860272:0.480935:0.844490:0.076183:0.844490:0.003024:0.009223:0.004007:0.010311:0.004551:0.009827:0.005020:0.010326:0.010357:0.003024:0.010311:0.009903:0.009782:0.008104:0.005125:0.009827:0.004007:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.009827:0.009223:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004007:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004007:0.003024:0.009223:0.004007:0.003024:0.009223:0.005866:0.009192:0.003024:0.003024:0.009223:0.004022:0.005866:0.009827:0.009223:0.005020
sitivity and release of aldosterone. The latter also causes :@0.076183:0.874450:0.485123:0.874450:0.485123:0.858667:0.076183:0.858667:0.005866:0.003024:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.003734:0.010326:0.009223:0.010357:0.003719:0.004551:0.009827:0.003024:0.009827:0.010326:0.005866:0.009827:0.003719:0.009903:0.004747:0.003704:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.004188:0.003704:0.006441:0.009223:0.009827:0.003704:0.003024:0.010326:0.005125:0.005125:0.009827:0.004551:0.003704:0.010326:0.003024:0.005866:0.009903:0.003719:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.004188
vasoconstriction and sodium and water retention with :@0.076183:0.888628:0.485138:0.888628:0.485138:0.872845:0.076183:0.872845:0.008376:0.010326:0.005866:0.009903:0.009782:0.009903:0.009223:0.005866:0.005125:0.004551:0.003024:0.009782:0.005125:0.003024:0.009903:0.009223:0.005881:0.010326:0.009223:0.010357:0.005881:0.005866:0.009903:0.010357:0.003024:0.009192:0.014182:0.005881:0.010326:0.009223:0.010357:0.005881:0.012564:0.010326:0.005125:0.009827:0.004551:0.005881:0.004551:0.009827:0.005125:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.005866:0.012564:0.003024:0.005125:0.009223:0.004188
putative potassium loss by stimulating up-regulation of :@0.076183:0.902806:0.485108:0.902806:0.485108:0.887023:0.076183:0.887023:0.010311:0.009192:0.005125:0.010326:0.005125:0.003024:0.008376:0.009827:0.005791:0.010311:0.009903:0.005125:0.010326:0.005866:0.005866:0.003024:0.009192:0.014182:0.005791:0.003024:0.009903:0.005866:0.005866:0.005791:0.010311:0.008104:0.005791:0.005866:0.005125:0.003024:0.014182:0.009192:0.003024:0.010326:0.005125:0.003024:0.009223:0.010175:0.005791:0.009192:0.010311:0.005020:0.004551:0.009827:0.010175:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005775:0.009903:0.004747:0.004188
the transporter system in the distal convoluted tube of :@0.076183:0.916983:0.485123:0.916983:0.485123:0.901201:0.076183:0.901201:0.005125:0.009223:0.009827:0.005534:0.005125:0.004551:0.010326:0.009223:0.005866:0.010311:0.009903:0.004551:0.005125:0.009827:0.004551:0.005518:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.005549:0.003024:0.009223:0.005534:0.005125:0.009223:0.009827:0.005534:0.010357:0.003024:0.005866:0.005125:0.010326:0.003024:0.005549:0.009782:0.009903:0.009223:0.008376:0.009903:0.003024:0.009192:0.005125:0.009827:0.010357:0.005534:0.005125:0.009192:0.010311:0.009827:0.005534:0.009903:0.004747:0.004188
the kidney. It is therefore easy to deduce that reducing :@0.076183:0.931161:0.485108:0.931161:0.485108:0.915379:0.076183:0.915379:0.005125:0.009223:0.009827:0.004309:0.007590:0.003024:0.010357:0.009223:0.009827:0.008104:0.004188:0.004309:0.003417:0.005125:0.004324:0.003024:0.005866:0.004324:0.005125:0.009223:0.009827:0.004551:0.009827:0.004747:0.009903:0.004551:0.009827:0.004294:0.009827:0.010326:0.005866:0.008104:0.004324:0.005125:0.009903:0.004309:0.010357:0.009827:0.010357:0.009192:0.009782:0.009827:0.004309:0.005125:0.009223:0.010326:0.005125:0.004309:0.004551:0.009827:0.010357:0.009192:0.009782:0.003024:0.009223:0.010175:0.004188
renin activity and blocking the ACE or the AT  receptor :@0.076183:0.945339:0.485147:0.945363:0.485147:0.929580:0.076183:0.929556:0.004551:0.009827:0.009223:0.003024:0.009223:0.004702:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.004717:0.010326:0.009223:0.010357:0.004702:0.010311:0.003024:0.009903:0.009782:0.007590:0.003024:0.009223:0.010175:0.004702:0.005125:0.009223:0.009827:0.004702:0.011188:0.012292:0.008104:0.004702:0.009903:0.004551:0.004702:0.005125:0.009223:0.009827:0.004702:0.011188:0.006441:0.004877:0.004702:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:-0.388742
1:@0.407519:0.945028:0.412377:0.945028:0.412377:0.935875:0.407519:0.935875:0.004858
or the aldosterone receptors or combinations of these, :@0.519044:0.168573:0.927999:0.168573:0.927999:0.152791:0.519044:0.152791:0.009903:0.004551:0.005065:0.005125:0.009223:0.009827:0.005065:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.005050:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.005866:0.005050:0.009903:0.004551:0.005050:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.005065:0.009903:0.004747:0.005065:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188:0.004188
should translate into clinical benefit and a reduction in :@0.519044:0.182716:0.927984:0.182716:0.927984:0.166934:0.519044:0.166934:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005020:0.005125:0.004551:0.010326:0.009223:0.005866:0.003024:0.010326:0.005125:0.009827:0.005020:0.003024:0.009223:0.005125:0.009903:0.005020:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.005035:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005020:0.010326:0.009223:0.010357:0.005020:0.010326:0.005020:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005020:0.003024:0.009223:0.004188
mortality. Unfortunately,  it took years for the develop-:@0.519044:0.196860:0.923796:0.196860:0.923796:0.181077:0.519044:0.181077:0.014182:0.009903:0.004551:0.005125:0.010326:0.003024:0.003024:0.005125:0.008104:0.004188:0.006486:0.009903:0.009223:0.004747:0.009903:0.004551:0.005125:0.009192:0.009223:0.010326:0.005125:0.009827:0.003024:0.008104:0.004188:0.004188:0.002283:0.003024:0.005125:0.006486:0.005125:0.009903:0.009888:0.007590:0.006486:0.008104:0.009827:0.010326:0.004551:0.005866:0.006486:0.004747:0.009903:0.004551:0.006486:0.005125:0.009223:0.009827:0.006486:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.005020
ment  of non-peptide renin  and angiotensin  receptor :@0.519044:0.211014:0.927999:0.211014:0.927999:0.195232:0.519044:0.195232:0.014182:0.009827:0.009223:0.005125:0.004188:0.003311:0.009903:0.004747:0.007514:0.009223:0.009903:0.009223:0.005020:0.010311:0.009827:0.010311:0.005125:0.003024:0.010357:0.009827:0.007514:0.004551:0.009827:0.009223:0.003024:0.009223:0.004188:0.003311:0.010326:0.009223:0.010357:0.007514:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.004188:0.003311:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.004188
blockers. The first products developed were the ACEIs :@0.519044:0.225158:0.927999:0.225158:0.927999:0.209375:0.519044:0.209375:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.004188:0.006093:0.006441:0.009223:0.009827:0.006078:0.003681:0.003681:0.004551:0.005866:0.005125:0.006093:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.005125:0.005866:0.006093:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.009827:0.010357:0.006093:0.012564:0.009827:0.004551:0.009827:0.006093:0.005125:0.009223:0.009827:0.006078:0.011188:0.012292:0.008104:0.003417:0.005866:0.004188
in the early 1980s, followed by the ARBs in the 1990s and :@0.519044:0.239301:0.927984:0.239301:0.927984:0.223518:0.519044:0.223518:0.003024:0.009223:0.003855:0.005125:0.009223:0.009827:0.003840:0.009827:0.010326:0.004551:0.003024:0.008104:0.003855:0.008376:0.008376:0.008391:0.008376:0.005866:0.004188:0.003855:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.009827:0.010357:0.003855:0.010311:0.008104:0.003855:0.005125:0.009223:0.009827:0.003840:0.011188:0.009177:0.008678:0.005866:0.003855:0.003024:0.009223:0.003855:0.005125:0.009223:0.009827:0.003840:0.008376:0.008376:0.008376:0.008376:0.005866:0.003870:0.010326:0.009223:0.010357:0.004188
renin blockers which were only registered in early 2000. :@0.519044:0.253444:0.927984:0.253444:0.927984:0.237661:0.519044:0.237661:0.004551:0.009827:0.009223:0.003024:0.009223:0.004778:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.004793:0.012564:0.009223:0.003024:0.009782:0.009223:0.004793:0.012564:0.009827:0.004551:0.009827:0.004793:0.009903:0.009223:0.003024:0.008104:0.004793:0.004551:0.009827:0.010175:0.003024:0.005866:0.005125:0.009827:0.004551:0.009827:0.010357:0.004778:0.003024:0.009223:0.004793:0.009827:0.010326:0.004551:0.003024:0.008104:0.004793:0.008376:0.008376:0.008376:0.008376:0.004188:0.004188
The big question then was “did it benefit the patient?” :@0.519044:0.267587:0.927999:0.267587:0.927999:0.251804:0.519044:0.251804:0.006441:0.009223:0.009827:0.005171:0.010311:0.003024:0.010175:0.005186:0.010311:0.009192:0.009827:0.005866:0.005125:0.003024:0.009903:0.009223:0.005171:0.005125:0.009223:0.009827:0.009223:0.005171:0.012564:0.010326:0.005866:0.005186:0.007590:0.010357:0.003024:0.010357:0.005186:0.003024:0.005125:0.005186:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005171:0.005125:0.009223:0.009827:0.005171:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.008935:0.007318:0.004188
and were combinations better as so-called ACEI es-:@0.519044:0.281730:0.923811:0.281730:0.923811:0.265948:0.519044:0.265948:0.010326:0.009223:0.010357:0.007771:0.012564:0.009827:0.004551:0.009827:0.007771:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.007771:0.010311:0.009827:0.005125:0.005125:0.009827:0.004551:0.007771:0.010326:0.005866:0.007771:0.005866:0.009903:0.005020:0.009782:0.010326:0.003024:0.003024:0.009827:0.010357:0.007771:0.011188:0.012292:0.008104:0.003417:0.007771:0.009827:0.005866:0.005020
cape and upregulation of angiotensin II in the presence :@0.519044:0.295873:0.927984:0.295873:0.927984:0.280091:0.519044:0.280091:0.009782:0.010326:0.010311:0.009827:0.003583:0.010326:0.009223:0.010357:0.003583:0.009192:0.010311:0.004551:0.009827:0.010175:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.003583:0.009903:0.004747:0.003583:0.010326:0.009223:0.010175:0.003024:0.009903:0.005125:0.009827:0.009223:0.005866:0.003024:0.009223:0.003583:0.003417:0.003417:0.003583:0.003024:0.009223:0.003583:0.005125:0.009223:0.009827:0.003583:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.009782:0.009827:0.004188
of ARBs occurred. The different disease manifestations :@0.519044:0.310028:0.928014:0.310028:0.928014:0.294245:0.519044:0.294245:0.009903:0.004747:0.005881:0.011188:0.009177:0.008678:0.005866:0.005881:0.009903:0.009782:0.009782:0.009192:0.004551:0.004536:0.009827:0.010357:0.004188:0.005881:0.006441:0.009223:0.009827:0.005881:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.009827:0.009223:0.005125:0.005881:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.005896:0.014182:0.010326:0.009223:0.003024:0.004747:0.009827:0.005866:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
are  highlighted below with  the  current  evidence for :@0.519044:0.324171:0.928014:0.324171:0.928014:0.308389:0.519044:0.308389:0.010326:0.004551:0.009827:0.004188:0.003840:0.009223:0.003024:0.010175:0.009223:0.003024:0.003024:0.010175:0.009223:0.005125:0.009827:0.010357:0.008043:0.010311:0.009827:0.003024:0.009903:0.012564:0.008043:0.012564:0.003024:0.005125:0.009223:0.004188:0.003840:0.005125:0.009223:0.009827:0.004188:0.003840:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.004188:0.003840:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.008043:0.004747:0.009903:0.004551:0.004188
clinical outcomes. :@0.519044:0.338314:0.656597:0.338314:0.656597:0.322532:0.519044:0.322532:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188:0.009903:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188:0.004188
HyPertensiOn:@0.519047:0.371251:0.648769:0.371251:0.648769:0.351086:0.519047:0.351086:0.012566:0.011457:0.010348:0.009609:0.010718:0.007761:0.009609:0.013674:0.009609:0.005174:0.015522:0.013674
1 :@0.648760:0.364775:0.657763:0.364775:0.657763:0.353079:0.648760:0.353079:0.006002:0.003001
All the currently available ACEIs, ARBs and renin blockers :@0.519047:0.387178:0.927972:0.387178:0.927972:0.371395:0.519047:0.371395:0.011188:0.003024:0.003024:0.003099:0.005125:0.009223:0.009827:0.003099:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.003099:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.003115:0.011188:0.012292:0.008104:0.003417:0.005866:0.004188:0.003099:0.011188:0.009177:0.008678:0.005866:0.003099:0.010326:0.009223:0.010357:0.003099:0.004551:0.009827:0.009223:0.003024:0.009223:0.003099:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.004188
effectively lower blood pressure, i.e. 10 mm Hg on aver-:@0.519047:0.401321:0.923814:0.401321:0.923814:0.385538:0.519047:0.385538:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.003024:0.008104:0.004082:0.003024:0.009903:0.012564:0.009827:0.004551:0.004082:0.010311:0.003024:0.009903:0.009903:0.010357:0.004082:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188:0.004082:0.003024:0.004188:0.009827:0.004188:0.004082:0.008376:0.008376:0.004082:0.014182:0.014182:0.004082:0.010326:0.010175:0.004082:0.009903:0.009223:0.004082:0.010326:0.008376:0.009827:0.004551:0.005020
age as all have flat dose-response curves. This means :@0.519047:0.415464:0.928002:0.415464:0.928002:0.399682:0.519047:0.399682:0.010326:0.010175:0.009827:0.006153:0.010326:0.005866:0.006153:0.010326:0.003024:0.003024:0.006153:0.009223:0.010326:0.008376:0.009827:0.006153:0.003666:0.003666:0.010326:0.005125:0.006153:0.010357:0.009903:0.005866:0.009827:0.005020:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.006153:0.009782:0.009192:0.004551:0.008376:0.009827:0.005866:0.004188:0.006153:0.006441:0.009223:0.003024:0.005866:0.006153:0.014182:0.009827:0.010326:0.009223:0.005866:0.004188
that  if the  blood-pressure  reduction  required  is more :@0.519047:0.429607:0.928002:0.429607:0.928002:0.413825:0.519047:0.413825:0.005125:0.009223:0.010326:0.005125:0.004188:0.003598:0.003024:0.004747:0.007801:0.005125:0.009223:0.009827:0.004188:0.003598:0.010311:0.003024:0.009903:0.009903:0.010357:0.005020:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188:0.003598:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003598:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.010357:0.004188:0.003598:0.003024:0.005866:0.007801:0.014182:0.009903:0.004551:0.009827:0.004188
than 10 mm Hg, these medications should be combined :@0.519047:0.443751:0.928002:0.443751:0.928002:0.427968:0.519047:0.427968:0.005125:0.009223:0.010326:0.009223:0.003281:0.008376:0.008376:0.003281:0.014182:0.014182:0.003281:0.010326:0.010175:0.004188:0.003281:0.005125:0.009223:0.009827:0.005866:0.009827:0.003281:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.003281:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003281:0.010311:0.009827:0.003281:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.009827:0.010357:0.004188
with either diuretics or calcium-channel blockers (CCBs) :@0.519047:0.457894:0.927987:0.457894:0.927987:0.442111:0.519047:0.442111:0.012564:0.003024:0.005125:0.009223:0.003659:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.003659:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.003659:0.009903:0.004551:0.003644:0.009782:0.010326:0.003024:0.009782:0.003024:0.009192:0.014182:0.005020:0.009782:0.009223:0.010326:0.009223:0.009223:0.009827:0.003024:0.003659:0.010311:0.003024:0.009903:0.009782:0.007590:0.009827:0.004551:0.005866:0.003659:0.005579:0.012292:0.012292:0.008678:0.005866:0.005579:0.004188
which will add an additional 5-10 mm Hg reduction. Of-:@0.519047:0.472037:0.923799:0.472037:0.923799:0.456254:0.519047:0.456254:0.012564:0.009223:0.003024:0.009782:0.009223:0.004097:0.012564:0.003024:0.003024:0.003024:0.004112:0.010326:0.010357:0.010357:0.004112:0.010326:0.009223:0.004097:0.010326:0.010357:0.010357:0.003024:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.004112:0.008376:0.005020:0.008376:0.008376:0.004112:0.014182:0.014182:0.004097:0.010326:0.010175:0.004097:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.004097:0.013138:0.004747:0.005020
ten patients with higher blood pressure need to start on :@0.519047:0.486180:0.928017:0.486180:0.928017:0.470397:0.519047:0.470397:0.005125:0.009827:0.009223:0.004218:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004218:0.012564:0.003024:0.005125:0.009223:0.004218:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004203:0.010311:0.003024:0.009903:0.009903:0.010357:0.004218:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004218:0.009223:0.009827:0.009827:0.010357:0.004218:0.005125:0.009903:0.004218:0.005866:0.005125:0.010326:0.004551:0.005125:0.004218:0.009903:0.009223:0.004188
combinations. The initial starting drug is usually an ACEI, :@0.519047:0.500323:0.928002:0.500323:0.928002:0.484541:0.519047:0.484541:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004294:0.006441:0.009223:0.009827:0.004294:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.004309:0.005866:0.005125:0.010326:0.004551:0.005125:0.003024:0.009223:0.010175:0.004294:0.010357:0.004551:0.009192:0.010175:0.004294:0.003024:0.005866:0.004294:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.004309:0.010326:0.009223:0.004294:0.011188:0.012292:0.008104:0.003417:0.004188:0.004188
but if not tolerated, an ARB is indicated. ACEIs or ARBs :@0.519047:0.514466:0.927987:0.514466:0.927987:0.498684:0.519047:0.498684:0.010311:0.009192:0.005125:0.005292:0.003024:0.004747:0.005292:0.009223:0.009903:0.005125:0.005292:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188:0.005277:0.010326:0.009223:0.005292:0.011188:0.009177:0.008678:0.005292:0.003024:0.005866:0.005292:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.004188:0.005292:0.011188:0.012292:0.008104:0.003417:0.005866:0.005292:0.009903:0.004551:0.005292:0.011188:0.009177:0.008678:0.005866:0.004188
combine well with CCBs (e.g. amlodipine) and diuretics :@0.519047:0.528610:0.927987:0.528610:0.927987:0.512827:0.519047:0.512827:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.009827:0.003946:0.012564:0.009827:0.003024:0.003024:0.003946:0.012564:0.003024:0.005125:0.009223:0.003946:0.012292:0.012292:0.008678:0.005866:0.003946:0.005579:0.009827:0.004188:0.010175:0.004188:0.003931:0.010326:0.014182:0.003024:0.009903:0.010357:0.003024:0.010311:0.003024:0.009223:0.009827:0.005579:0.003946:0.010326:0.009223:0.010357:0.003946:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.005866:0.004188
such as indapamide (metabolically neutral). The type :@0.519047:0.542753:0.927987:0.542753:0.927987:0.526970:0.519047:0.526970:0.005866:0.009192:0.009782:0.009223:0.006350:0.010326:0.005866:0.006350:0.003024:0.009223:0.010357:0.010326:0.010311:0.010326:0.014182:0.003024:0.010357:0.009827:0.006350:0.005579:0.014182:0.009827:0.005125:0.010326:0.010311:0.009903:0.003024:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.006365:0.009223:0.009827:0.009192:0.005125:0.004551:0.010326:0.003024:0.005579:0.004188:0.006335:0.006441:0.009223:0.009827:0.006335:0.005125:0.008104:0.010311:0.009827:0.004188
of ACEI or ARB is perhaps less important if the problem :@0.519047:0.556896:0.927972:0.556896:0.927972:0.541113:0.519047:0.541113:0.009903:0.004747:0.005186:0.011188:0.012292:0.008104:0.003417:0.005186:0.009903:0.004551:0.005186:0.011188:0.009177:0.008678:0.005186:0.003024:0.005866:0.005201:0.010311:0.009827:0.004551:0.009223:0.010326:0.010311:0.005866:0.005186:0.003024:0.009827:0.005866:0.005866:0.005186:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.005186:0.003024:0.004747:0.005186:0.005125:0.009223:0.009827:0.005186:0.010311:0.004551:0.009903:0.010311:0.003024:0.009827:0.014182:0.004188
is restricted to hypertension. When blood pressure (Bp) :@0.519047:0.571039:0.928002:0.571039:0.928002:0.555257:0.519047:0.555257:0.003024:0.005866:0.005624:0.004551:0.009827:0.005866:0.005125:0.004551:0.003024:0.009782:0.005125:0.009827:0.010357:0.005624:0.005125:0.009903:0.005624:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188:0.005609:0.014514:0.009223:0.009827:0.009223:0.005624:0.010311:0.003024:0.009903:0.009903:0.010357:0.005624:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.005624:0.005579:0.008678:0.008950:0.005579:0.004188
variability is important, then a longer-acting agent, such :@0.519047:0.585182:0.927987:0.585182:0.927987:0.569400:0.519047:0.569400:0.008376:0.010326:0.004551:0.003024:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.003538:0.003024:0.005866:0.003538:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.004188:0.003508:0.005125:0.009223:0.009827:0.009223:0.003523:0.010326:0.003523:0.003024:0.009903:0.009223:0.010175:0.009827:0.004551:0.005020:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.003508:0.010326:0.010175:0.009827:0.009223:0.005125:0.004188:0.003523:0.005866:0.009192:0.009782:0.009223:0.004188
as perindopril (ACEI) or telmisartan (ARB), makes more :@0.519047:0.599325:0.928002:0.599325:0.928002:0.583543:0.519047:0.583543:0.010326:0.005866:0.005518:0.010311:0.009827:0.004551:0.003024:0.009223:0.010357:0.009903:0.010311:0.004551:0.003024:0.003024:0.005518:0.005579:0.011188:0.012292:0.008104:0.003417:0.005579:0.005518:0.009903:0.004551:0.005503:0.005125:0.009827:0.003024:0.014182:0.003024:0.005866:0.010326:0.004551:0.005125:0.010326:0.009223:0.005518:0.005579:0.011188:0.009177:0.008678:0.005579:0.004188:0.005518:0.014182:0.010326:0.007590:0.009827:0.005866:0.005518:0.014182:0.009903:0.004551:0.009827:0.004188
sense. Adding a diuretic to  either  an ACE or  an ARB :@0.519047:0.613469:0.928002:0.613469:0.928002:0.597686:0.519047:0.597686:0.005866:0.009827:0.009223:0.005866:0.009827:0.004188:0.006970:0.011188:0.010357:0.010357:0.003024:0.009223:0.010175:0.006970:0.010326:0.006970:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.006970:0.005125:0.009903:0.004188:0.002767:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.004188:0.002767:0.010326:0.009223:0.006970:0.011188:0.012292:0.008104:0.006970:0.009903:0.004551:0.004188:0.002767:0.010326:0.009223:0.006970:0.011188:0.009177:0.008678:0.004188
also increases the duration of action and reduces Bp :@0.519047:0.627612:0.927987:0.627612:0.927987:0.611829:0.519047:0.611829:0.010326:0.003024:0.005866:0.009903:0.006562:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005866:0.006562:0.005125:0.009223:0.009827:0.006562:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.006562:0.009903:0.004747:0.006562:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.006562:0.010326:0.009223:0.010357:0.006562:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.005866:0.006562:0.008678:0.008950:0.004188
variability. Only in step 4 would one add an aldosterone :@0.519047:0.641755:0.928002:0.641755:0.928002:0.625972:0.519047:0.625972:0.008376:0.010326:0.004551:0.003024:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004188:0.003750:0.013138:0.009223:0.003024:0.008104:0.003734:0.003024:0.009223:0.003734:0.005866:0.005125:0.009827:0.010311:0.003734:0.008376:0.003734:0.012564:0.009903:0.009192:0.003024:0.010357:0.003734:0.009903:0.009223:0.009827:0.003719:0.010326:0.010357:0.010357:0.003734:0.010326:0.009223:0.003734:0.010326:0.003024:0.010357:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.009223:0.009827:0.004188
antagonist as a diuretic, provided the serum potassium :@0.519047:0.655898:0.927972:0.655898:0.927972:0.640116:0.519047:0.640116:0.010326:0.009223:0.005125:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.004642:0.010326:0.005866:0.004657:0.010326:0.004657:0.010357:0.003024:0.009192:0.004551:0.009827:0.005125:0.003024:0.009782:0.004188:0.004642:0.010311:0.004551:0.009903:0.008376:0.003024:0.010357:0.009827:0.010357:0.004657:0.005125:0.009223:0.009827:0.004642:0.005866:0.009827:0.004551:0.009192:0.014182:0.004642:0.010311:0.009903:0.005125:0.010326:0.005866:0.005866:0.003024:0.009192:0.014182:0.004188
is below 4.5 mmol/L. All ACEIs and ARBs are registered :@0.519047:0.670041:0.928017:0.670041:0.928017:0.654259:0.519047:0.654259:0.003024:0.005866:0.005503:0.010311:0.009827:0.003024:0.009903:0.012564:0.005503:0.008376:0.004188:0.008376:0.005503:0.014182:0.014182:0.009903:0.003024:0.006607:0.006985:0.004188:0.005488:0.011188:0.003024:0.003024:0.005503:0.011188:0.012292:0.008104:0.003417:0.005866:0.005503:0.010326:0.009223:0.010357:0.005503:0.011188:0.009177:0.008678:0.005866:0.005503:0.010326:0.004551:0.009827:0.005488:0.004551:0.009827:0.010175:0.003024:0.005866:0.005125:0.009827:0.004551:0.009827:0.010357:0.004188
for hypertension.:@0.519047:0.684185:0.640831:0.684185:0.640831:0.668402:0.519047:0.668402:0.004747:0.009903:0.004551:0.004188:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.009827:0.009223:0.005866:0.003024:0.009903:0.009223:0.004188
HeArt fAilure:@0.519047:0.717202:0.646551:0.717202:0.646551:0.697037:0.519047:0.697037:0.012566:0.009609:0.013674:0.010718:0.007761:0.005174:0.008870:0.013674:0.005174:0.008131:0.011826:0.010718:0.009609
2 :@0.646540:0.710726:0.655543:0.710726:0.655543:0.699030:0.646540:0.699030:0.006002:0.003001
Activation of the  RAAs  is pivotal in heart  failure (HF), :@0.519047:0.733129:0.928002:0.733129:0.928002:0.717346:0.519047:0.717346:0.011188:0.009782:0.005125:0.003024:0.008376:0.010326:0.005125:0.003024:0.009903:0.009223:0.007091:0.009903:0.004747:0.007091:0.005125:0.009223:0.009827:0.004188:0.002888:0.009177:0.011188:0.011188:0.007529:0.004188:0.002888:0.003024:0.005866:0.007091:0.010311:0.003024:0.008391:0.009903:0.005125:0.010326:0.003024:0.007091:0.003024:0.009223:0.007091:0.009223:0.009827:0.010326:0.004551:0.005125:0.004188:0.002888:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.007091:0.005579:0.010326:0.007333:0.005579:0.004188:0.004188
again making a RAAs antagonist a logical choice, and :@0.519047:0.747272:0.927987:0.747272:0.927987:0.731489:0.519047:0.731489:0.010326:0.010175:0.010326:0.003024:0.009223:0.004279:0.014182:0.010326:0.007590:0.003024:0.009223:0.010175:0.004279:0.010326:0.004279:0.009177:0.011188:0.011188:0.007529:0.004264:0.010326:0.009223:0.005125:0.010326:0.010175:0.009903:0.009223:0.003024:0.005866:0.005125:0.004279:0.010326:0.004279:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004279:0.009782:0.009223:0.009903:0.003024:0.009782:0.009827:0.004188:0.004279:0.010326:0.009223:0.010357:0.004188
most  ACEIs have been  researched  for  this indication. :@0.519047:0.761415:0.927987:0.761415:0.927987:0.745632:0.519047:0.745632:0.014182:0.009903:0.005866:0.005125:0.004188:0.002676:0.011188:0.012292:0.008104:0.003417:0.005866:0.006879:0.009223:0.010326:0.008376:0.009827:0.006879:0.010311:0.009827:0.009827:0.009223:0.004188:0.002676:0.004551:0.009827:0.005866:0.009827:0.010326:0.004551:0.009782:0.009223:0.009827:0.010357:0.004188:0.002676:0.004747:0.009903:0.004551:0.004188:0.002676:0.005125:0.009223:0.003024:0.005866:0.006879:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
Ramipril, perindopril, trandolapril and lisinopril  can be :@0.519047:0.775558:0.927987:0.775558:0.927987:0.759776:0.519047:0.759776:0.009177:0.010326:0.014182:0.003024:0.010311:0.004551:0.003024:0.003024:0.004188:0.007091:0.010311:0.009827:0.004551:0.003024:0.009223:0.010357:0.009903:0.010311:0.004551:0.003024:0.003024:0.004188:0.007091:0.005125:0.004551:0.010326:0.009223:0.010357:0.009903:0.003024:0.010326:0.010311:0.004551:0.003024:0.003024:0.007091:0.010326:0.009223:0.010357:0.007091:0.003024:0.003024:0.005866:0.003024:0.009223:0.009903:0.010311:0.004551:0.003024:0.003024:0.004188:0.002918:0.009782:0.010326:0.009223:0.007091:0.010311:0.009827:0.004188
given once  daily, whereas captopril should be taken :@0.519047:0.789701:0.927987:0.789701:0.927987:0.773919:0.519047:0.773919:0.010175:0.003024:0.008376:0.009827:0.009223:0.006864:0.009903:0.009223:0.009782:0.009827:0.004188:0.002661:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.006864:0.012564:0.009223:0.009827:0.004551:0.009827:0.010326:0.005866:0.006864:0.009782:0.010326:0.010311:0.005125:0.009903:0.010311:0.004551:0.003024:0.003024:0.006864:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.006864:0.010311:0.009827:0.006864:0.005125:0.010326:0.007590:0.009827:0.009223:0.004188
three times per day and enalapril and quinapril twice :@0.519047:0.803845:0.927987:0.803845:0.927987:0.788062:0.519047:0.788062:0.005125:0.009223:0.004551:0.009827:0.009827:0.005987:0.005125:0.003024:0.014182:0.009827:0.005866:0.005987:0.010311:0.009827:0.004551:0.005987:0.010357:0.010326:0.008104:0.006002:0.010326:0.009223:0.010357:0.005987:0.009827:0.009223:0.010326:0.003024:0.010326:0.010311:0.004551:0.003024:0.003024:0.006002:0.010326:0.009223:0.010357:0.005987:0.010311:0.009192:0.003024:0.009223:0.010326:0.010311:0.004551:0.003024:0.003024:0.006002:0.005125:0.012564:0.003024:0.009782:0.009827:0.004188
daily. Although well researched,  fewer  ARBs record  a :@0.519047:0.817988:0.927987:0.817988:0.927987:0.802205:0.519047:0.802205:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.006607:0.011188:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009207:0.006607:0.012564:0.009827:0.003024:0.003024:0.006607:0.004551:0.009827:0.005866:0.009827:0.010326:0.004551:0.009782:0.009223:0.009827:0.010357:0.004188:0.004188:0.002404:0.004747:0.009827:0.012564:0.009827:0.004551:0.004188:0.002404:0.011188:0.009177:0.008678:0.005866:0.006607:0.004551:0.009827:0.009782:0.009903:0.004551:0.010357:0.004188:0.002404:0.010326:0.004188
registered indication for treating heart failure; those in-:@0.519047:0.832131:0.923799:0.832131:0.923799:0.816348:0.519047:0.816348:0.004551:0.009827:0.010175:0.003024:0.005866:0.005125:0.009827:0.004551:0.009827:0.010357:0.005261:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005277:0.004747:0.009903:0.004551:0.005277:0.005125:0.004551:0.009827:0.010326:0.005125:0.003024:0.009223:0.010175:0.005261:0.009223:0.009827:0.010326:0.004551:0.005125:0.005261:0.004747:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.004188:0.005277:0.005125:0.009223:0.009903:0.005866:0.009827:0.005277:0.003024:0.009223:0.005020
dicated are valsartan, candesartan and losartan. Most :@0.519047:0.846274:0.927987:0.846274:0.927987:0.830491:0.519047:0.830491:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.004626:0.010326:0.004551:0.009827:0.004626:0.008376:0.010326:0.003024:0.005866:0.010326:0.004551:0.005125:0.010326:0.009223:0.004188:0.004626:0.009782:0.010326:0.009223:0.010357:0.009827:0.005866:0.010326:0.004551:0.005125:0.010326:0.009223:0.004626:0.010326:0.009223:0.010357:0.004626:0.003024:0.009903:0.005866:0.010326:0.004551:0.005125:0.010326:0.009223:0.004188:0.004626:0.013894:0.009903:0.005866:0.005125:0.004188
patients (>50%) did not reach the study target dosages :@0.519047:0.860417:0.927972:0.860417:0.927972:0.844635:0.519047:0.844635:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004400:0.005579:0.009162:0.008376:0.008376:0.011717:0.005579:0.004400:0.010357:0.003024:0.010357:0.004400:0.009223:0.009903:0.005125:0.004385:0.004551:0.009827:0.010326:0.009782:0.009223:0.004385:0.005125:0.009223:0.009827:0.004400:0.005866:0.005125:0.009192:0.010357:0.008104:0.004400:0.005125:0.010326:0.004551:0.010175:0.009827:0.005125:0.004385:0.010357:0.009903:0.005866:0.010326:0.010175:0.009827:0.005866:0.004188
of either medicine type, mostly due to tolerance. A re-:@0.519047:0.874560:0.923799:0.874560:0.923799:0.858778:0.519047:0.858778:0.009903:0.004747:0.004974:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.004974:0.014182:0.009827:0.010357:0.003024:0.009782:0.003024:0.009223:0.009827:0.004974:0.005125:0.008104:0.010311:0.009827:0.004188:0.004974:0.014182:0.009903:0.005866:0.005125:0.003024:0.008104:0.004974:0.010357:0.009192:0.009827:0.004974:0.005125:0.009903:0.004974:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.009223:0.009782:0.009827:0.004188:0.004959:0.011188:0.004974:0.004551:0.009827:0.005020
cent meta-analysis demonstrated that the idea of start-:@0.519047:0.888715:0.923814:0.888715:0.923814:0.872932:0.519047:0.872932:0.009782:0.009827:0.009223:0.005125:0.003961:0.014182:0.009827:0.005125:0.010326:0.005020:0.010326:0.009223:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.003976:0.010357:0.009827:0.014182:0.009903:0.009223:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.010357:0.003946:0.005125:0.009223:0.010326:0.005125:0.003961:0.005125:0.009223:0.009827:0.003961:0.003024:0.010357:0.009827:0.010326:0.003961:0.009903:0.004747:0.003961:0.005866:0.005125:0.010326:0.004551:0.005125:0.005020
ing with a lower dose and titrating to the highest toler-:@0.519047:0.902858:0.923829:0.902858:0.923829:0.887076:0.519047:0.887076:0.003024:0.009223:0.010175:0.005156:0.012564:0.003024:0.005125:0.009223:0.005156:0.010326:0.005156:0.003024:0.009903:0.012564:0.009827:0.004551:0.005156:0.010357:0.009903:0.005866:0.009827:0.005156:0.010326:0.009223:0.010357:0.005156:0.005125:0.003024:0.005125:0.004551:0.010326:0.005125:0.003024:0.009223:0.010175:0.005156:0.005125:0.009903:0.005156:0.005125:0.009223:0.009827:0.005156:0.009223:0.003024:0.010175:0.009223:0.009827:0.005866:0.005125:0.005156:0.005125:0.009903:0.003024:0.009827:0.004551:0.005020
able dose of either agent is actually acceptable.  The :@0.519047:0.917001:0.928001:0.917065:0.928001:0.901282:0.519047:0.901219:0.010326:0.010311:0.003024:0.009827:0.005428:0.010357:0.009903:0.005866:0.009827:0.005428:0.009903:0.004747:0.005428:0.009827:0.003024:0.005125:0.009223:0.009827:0.004551:0.005428:0.010326:0.010175:0.009827:0.009223:0.005125:0.005428:0.003024:0.005866:0.005443:0.010326:0.009782:0.005125:0.009192:0.010326:0.003024:0.003024:0.008104:0.005428:0.010326:0.009782:0.009782:0.009827:0.010311:0.005125:0.010326:0.010311:0.003024:0.009827:0.004188:0.004867:0.005428:0.006441:0.009223:0.009827:-0.794540
3:@0.888035:0.911766:0.892893:0.911766:0.892893:0.902612:0.888035:0.902612:0.004858
authors state that higher dosages of ACEIs and ARBs re-:@0.519046:0.931208:0.923813:0.931208:0.923813:0.915425:0.519046:0.915425:0.010326:0.009192:0.005125:0.009223:0.009903:0.004551:0.005866:0.004037:0.005866:0.005125:0.010326:0.005125:0.009827:0.004052:0.005125:0.009223:0.010326:0.005125:0.004052:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004037:0.010357:0.009903:0.005866:0.010326:0.010175:0.009827:0.005866:0.004052:0.009903:0.004747:0.004052:0.011188:0.012292:0.008104:0.003417:0.005866:0.004052:0.010326:0.009223:0.010357:0.004052:0.011188:0.009177:0.008678:0.005866:0.004052:0.004551:0.009827:0.005020
duce the risk of HF worsening compared to lower doses, :@0.519046:0.945351:0.928016:0.945351:0.928016:0.929569:0.519046:0.929569:0.010357:0.009192:0.009782:0.009827:0.003734:0.005125:0.009223:0.009827:0.003734:0.004551:0.003024:0.005866:0.007590:0.003734:0.009903:0.004747:0.003734:0.010326:0.007333:0.003734:0.012564:0.009903:0.004551:0.005866:0.009827:0.009223:0.003024:0.009223:0.010175:0.003734:0.009782:0.009903:0.014182:0.010311:0.010326:0.004551:0.009827:0.010357:0.003734:0.005125:0.009903:0.003734:0.003024:0.009903:0.012564:0.009827:0.004551:0.003734:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188:0.004188